Strides Pharma Science per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹66.91₹60.34₹390.54−₹7.76−₹22.49
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹66.90₹60.34₹390.50−₹7.77−₹22.49
₹337.14₹337.14₹276.88₹231.29₹244.98
₹565.59₹527.13₹495.35₹440.82₹408.45
—₹76.22₹74.26₹76.29₹4.92
₹30.33₹30.33₹47.95₹63.43−₹5.60
—₹4.00₹2.49₹1.47₹0.00
9.29.29.29.29.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

STAR₹1,097.50

Strides Pharma Science Ltd.

· Pharma & Health
₹ CrorePeersSPARCSUPRIYASHILPAMEDTHYROCARERUBICONVIYASHYATHARTHPARKHOSPSMcap ₹10,116 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS-22.49-7.76390.5460.3466.91
Diluted EPS-22.49-7.77390.5060.3466.90
Book Value per Share244.98231.29276.88337.14337.14
Revenue per Share408.45440.82495.35527.13565.59
Cash Flow per Share4.9276.2974.2676.22—
Free Cash Flow per Share-5.6063.4347.9530.3330.33
Dividends per Share0.001.472.494.00—
Shares Outstanding (cr)9.09.29.29.29.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.